The document discusses strategies for emergency departments to respond to COVID-19. It notes that many patients present with mild or no symptoms, so widespread screening is needed but imperfect. Healthcare workers are at high risk of infection due to limitations in identifying cases and protective equipment shortages. The document recommends establishing outdoor screening checkpoints to quickly isolate potential cases without overburdening limited indoor isolation rooms. It also suggests using video conferencing to minimize unnecessary staff exposures while allowing isolated physicians to work remotely. Changing practices is urgent to reduce risks to staff and prevent hospitals from becoming sites of further virus spread. However, regulations focused on normal operations now hinder crisis-appropriate responses and rapid technology deployment. Leveraging industry aid could help address constraints.
Risk Management and Patient Safety Evolution and Progress. Charles Vincent. Match Safety critical component of quality (Madrid, Ministry of Health and Consumer Affairs, 2005)
Please view this video on Emergency Preparedness Planning from the CHC's Weitzman Institute focusing on the role of FQHC leadership, staff support, and key strategies for preparedness and easing anxiety.
Risk Management and Patient Safety Evolution and Progress. Charles Vincent. Match Safety critical component of quality (Madrid, Ministry of Health and Consumer Affairs, 2005)
Please view this video on Emergency Preparedness Planning from the CHC's Weitzman Institute focusing on the role of FQHC leadership, staff support, and key strategies for preparedness and easing anxiety.
Introducing Comprehensive, Concurrent Patient Safety Surveillance for Hospita...Health Catalyst
Health Catalyst is excited to announce the Patient Safety Monitor™ Suite: Surveillance Module, the industry’s first comprehensive patient safety application to use predictive and text analytics combined with concurrent clinician review of data to help monitor, detect, predict and prevent threats to patients before harm can occur.
The Patient Safety Monitor Suite leverages AI and machine learning to quickly identify patterns of harm, learn from those patterns, and suggest strategies to eliminate patient safety risks and hazards. This potent combination of AI, machine learning, text analytics and near real-time data from multiple IT systems enables the Patient Safety Monitor Suite to predict harm events and guide clinical interventions while the patient is still in the hospital.
In this webinar you will learn how the Surveillance Module can provide:
* Greater clarity to the types, numbers, and causes of adverse events, enabling leaders to quickly prioritize improvement efforts.
* Improved patient outcomes such as reduced morbidity, mortality, and length-of-stay, and increased quality-of-life and satisfaction.
* Bottom-line cost savings and improved brand recognition related to unnecessary or preventable high-cost care and reduced/eliminated penalties.
* The ability for clinicians and infection preventionists to focus on patient care instead of burdensome manual data extraction, aggregation, and reporting.
Introducing the Next-Gen Patient Safety OrganizationHealth Catalyst
Eliminating avoidable harm is a problem that we can and should solve. The journey to become highly reliable at producing meaningful and sustainable outcomes improvements requires organizations to maximize their investments in safety.
Safety improvements are the result of people, and process changes with data-driven insights as the underlying secret ingredient, but most PSOs are missing this tight integration between the three. Does your PSO?
View this webinar announcing the next generation Health Catalyst Patient Safety Organization (HC PSO) and learn why coupling it with the Health Catalyst Patient Safety Monitor™ Suite—built by patient safety experts for patient safety experts—is such an important differentiator. Leading in this product announcement are two experts in patient safety, Michael Barton and Elaine St. James. In this webinar they share the following:
- Importance of active safety surveillance and analysis to discover safety vulnerabilities that are often overlooked.
- Operational efficiency and organizational risk avoidance available by hosting together the safety analytics and HC PSO.
- Effective safety governance and application of safety best practices that will improve outcomes in a measurable, and sustainable way.
- Integration of analytics, and benchmarking from a health care Data Operating System (DOS).
Implementation of an active trigger surveillance tool into your existing system is just one step on your safety journey. Eliminating preventable harm requires commitment to change, organizational buy-in and a number of key components that will be discussed in this webinar. We hope that you will view the webinar.
Presentation at 2007 Annual Meeting of VA Patient Safety Managers and OfficersNoel Eldridge
This presentation was for 150 or so Dept of VA Patient Safety managers with and for whom I worked at VA Central Office while they worked at the VA Medical Centers and Network offices. The main items of interest are the preliminary work that I was describing from the periphery of the then developing VA MRSA Prevention Program, which was quite successful and led by Dr. Rajiv Jain (and published in NEJM: http://www.nejm.org/doi/full/10.1056/NEJMoa1007474#t=abstract). Also of interest is the wide-ranging work that VA NCPS led on the follow up on an OIG report that identified problems in some of VA's operating rooms. Also of interest is slide 36 where I present some interesting data on VA's reduction in unadjusted inpatient mortality - this hasn't been widely publicized or published to my knowledge. The second to last slide refers to the fact that the day after the meeting I was going to the Grand Canyon and planning to hike to the bottom one day and out the next day. That turned out to be a great experience.
Joint Commission and Patients for Patient Safety. Laura Botwinick. III International Conference on Patient Safety: "Patients for Patient Safety" (Madrid, Ministry of Health and Consumer Affairs, 2007)
Objectives:
•Further to the launch of the revised SSI Getting Started Kit and improved measures, to introduce a new audit tool; Data Collection Form (DCF) and complementary data base which allows teams to collect patient level data on specific SSI prevention related process and outcome measures.
•To demonstrate how this data can be easily submitted and analyzed through the Patient Safety Metrics system and used to accelerate your quality improvement initiatives
WATCH: http://bit.ly/1GGtOpX
Retaining Healthcare Quality During COVID-19 and Future of Care Delivery. By....Healthcare consultant
With the onset of COVID-19, healthcare delivery organizations around the world were collectively faced with one primary challenge: How to effectively deliver quality healthcare to all patients, regardless of the entry point into the system, while protecting the well-being of non-COVID-19 patients and the healthcare workforce.
Best practices from the field how one health center battles covid 19Compliatric
In March 2020, COVID-19 started to affect the way FQHCs provided care. Changing the perception and the way health care is provided can normally take months to years to ensure a smooth transition. As we know, FQHCs did not have that time to adapt. Come and learn from your peers! Cabarrus Rowan Community Health Center (CRCHC), located in Concord, NC, had to adapt quickly and are now one of the state's testing centers. Participants will learn how one health center changed their clinical practices in order to meet the care of their community and also ensured that staff was ready to provide care.
Operational Planning of Hospitals towards COVID 19 Pandemic- Indian PerspectiveLallu Joseph
This presentation is about the preparation of Indian Hospitals towards managing patients during the COVID 19 Pandemic. This is based on experience shared by hospitals for the benefit of other hospitals to prepare themselves. How to set up the Hospital Incident Command System, components of managing the pandemic like infection control, Engineering Controls, Patient flow and Triaging, Supply chain management including PPE, Clinical management, Manpower management and shifts, Training.
Introducing Comprehensive, Concurrent Patient Safety Surveillance for Hospita...Health Catalyst
Health Catalyst is excited to announce the Patient Safety Monitor™ Suite: Surveillance Module, the industry’s first comprehensive patient safety application to use predictive and text analytics combined with concurrent clinician review of data to help monitor, detect, predict and prevent threats to patients before harm can occur.
The Patient Safety Monitor Suite leverages AI and machine learning to quickly identify patterns of harm, learn from those patterns, and suggest strategies to eliminate patient safety risks and hazards. This potent combination of AI, machine learning, text analytics and near real-time data from multiple IT systems enables the Patient Safety Monitor Suite to predict harm events and guide clinical interventions while the patient is still in the hospital.
In this webinar you will learn how the Surveillance Module can provide:
* Greater clarity to the types, numbers, and causes of adverse events, enabling leaders to quickly prioritize improvement efforts.
* Improved patient outcomes such as reduced morbidity, mortality, and length-of-stay, and increased quality-of-life and satisfaction.
* Bottom-line cost savings and improved brand recognition related to unnecessary or preventable high-cost care and reduced/eliminated penalties.
* The ability for clinicians and infection preventionists to focus on patient care instead of burdensome manual data extraction, aggregation, and reporting.
Introducing the Next-Gen Patient Safety OrganizationHealth Catalyst
Eliminating avoidable harm is a problem that we can and should solve. The journey to become highly reliable at producing meaningful and sustainable outcomes improvements requires organizations to maximize their investments in safety.
Safety improvements are the result of people, and process changes with data-driven insights as the underlying secret ingredient, but most PSOs are missing this tight integration between the three. Does your PSO?
View this webinar announcing the next generation Health Catalyst Patient Safety Organization (HC PSO) and learn why coupling it with the Health Catalyst Patient Safety Monitor™ Suite—built by patient safety experts for patient safety experts—is such an important differentiator. Leading in this product announcement are two experts in patient safety, Michael Barton and Elaine St. James. In this webinar they share the following:
- Importance of active safety surveillance and analysis to discover safety vulnerabilities that are often overlooked.
- Operational efficiency and organizational risk avoidance available by hosting together the safety analytics and HC PSO.
- Effective safety governance and application of safety best practices that will improve outcomes in a measurable, and sustainable way.
- Integration of analytics, and benchmarking from a health care Data Operating System (DOS).
Implementation of an active trigger surveillance tool into your existing system is just one step on your safety journey. Eliminating preventable harm requires commitment to change, organizational buy-in and a number of key components that will be discussed in this webinar. We hope that you will view the webinar.
Presentation at 2007 Annual Meeting of VA Patient Safety Managers and OfficersNoel Eldridge
This presentation was for 150 or so Dept of VA Patient Safety managers with and for whom I worked at VA Central Office while they worked at the VA Medical Centers and Network offices. The main items of interest are the preliminary work that I was describing from the periphery of the then developing VA MRSA Prevention Program, which was quite successful and led by Dr. Rajiv Jain (and published in NEJM: http://www.nejm.org/doi/full/10.1056/NEJMoa1007474#t=abstract). Also of interest is the wide-ranging work that VA NCPS led on the follow up on an OIG report that identified problems in some of VA's operating rooms. Also of interest is slide 36 where I present some interesting data on VA's reduction in unadjusted inpatient mortality - this hasn't been widely publicized or published to my knowledge. The second to last slide refers to the fact that the day after the meeting I was going to the Grand Canyon and planning to hike to the bottom one day and out the next day. That turned out to be a great experience.
Joint Commission and Patients for Patient Safety. Laura Botwinick. III International Conference on Patient Safety: "Patients for Patient Safety" (Madrid, Ministry of Health and Consumer Affairs, 2007)
Objectives:
•Further to the launch of the revised SSI Getting Started Kit and improved measures, to introduce a new audit tool; Data Collection Form (DCF) and complementary data base which allows teams to collect patient level data on specific SSI prevention related process and outcome measures.
•To demonstrate how this data can be easily submitted and analyzed through the Patient Safety Metrics system and used to accelerate your quality improvement initiatives
WATCH: http://bit.ly/1GGtOpX
Retaining Healthcare Quality During COVID-19 and Future of Care Delivery. By....Healthcare consultant
With the onset of COVID-19, healthcare delivery organizations around the world were collectively faced with one primary challenge: How to effectively deliver quality healthcare to all patients, regardless of the entry point into the system, while protecting the well-being of non-COVID-19 patients and the healthcare workforce.
Best practices from the field how one health center battles covid 19Compliatric
In March 2020, COVID-19 started to affect the way FQHCs provided care. Changing the perception and the way health care is provided can normally take months to years to ensure a smooth transition. As we know, FQHCs did not have that time to adapt. Come and learn from your peers! Cabarrus Rowan Community Health Center (CRCHC), located in Concord, NC, had to adapt quickly and are now one of the state's testing centers. Participants will learn how one health center changed their clinical practices in order to meet the care of their community and also ensured that staff was ready to provide care.
Operational Planning of Hospitals towards COVID 19 Pandemic- Indian PerspectiveLallu Joseph
This presentation is about the preparation of Indian Hospitals towards managing patients during the COVID 19 Pandemic. This is based on experience shared by hospitals for the benefit of other hospitals to prepare themselves. How to set up the Hospital Incident Command System, components of managing the pandemic like infection control, Engineering Controls, Patient flow and Triaging, Supply chain management including PPE, Clinical management, Manpower management and shifts, Training.
The time between initial exposure to the virus and the appearance of symptoms is known as the incubation period. This period is typically four to five days, although it can last up to 14 days, or perhaps even longer in rare cases.
An infection occurring in a patient in a hospital or other health care facility in whom the infection was not present or incubating at the time of admission. This includes infection acquired in hospital but appearing after discharge, and also occupational infection among staff of the facility.
International Patient Safety Goals (IPSG) help accredited organizations address specific areas of concern in some of the most problematic areas of patient safety.
International-Patient-Safety-GoalsGoal 1: Identify patients correctly
Goal 2: Improve effective communication
Goal 3: Improve the safety of high-alert medications
Goal 4: Ensure safe surgery
Goal 5: Reduce the risk of health care-associated infections
Goal 6: Reduce the risk of patient harm resulting from falls
Surgical practice during covid 19 pandemic- Dr H V ShivaramDr.Shivaram HV
This very popular talk narrates in detail the way to go ahead with safe surgical practice especially in India during the Covid-19 pandemic. It is useful for all types of practice and all types of surgeons whether they operate or teach or do only do outpatient practice
Corna virus detail And corona virus in pakistanEmaan Uppal
The 2019–20 coronavirus pandemic is a pandemic of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The disease was first identified in Wuhan, Hubei, China in December 2019Avoiding close contact with sick individuals; frequently washing hands with soap and water; not touching the eyes, nose, or mouth with unwashed hands; and practicing good respiratory hygiene.
Deep Dive Into Telehealth Adoption Covid 19 and Beyond | Doreen Amatelli ClarkVSee
For more info: visit https://bit.ly/3pt6hp2
How has telehealth adoption changed following the pandemic and what are the implications for the future of telehealth? Join market research expert and owner of Way to Goal, Doreen Amatelli-Clark to talk about her latest findings from her COVID-19 study, covering surveys and in-depth interviews with doctors and healthcare practitioners from around the world.
Provided to you by: https://vsee.com
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAkankshaAshtankar
MIP 201T & MPH 202T
ADVANCED BIOPHARMACEUTICS & PHARMACOKINETICS : UNIT 5
APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS By - AKANKSHA ASHTANKAR
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
CDSCO and Phamacovigilance {Regulatory body in India}NEHA GUPTA
The Central Drugs Standard Control Organization (CDSCO) is India's national regulatory body for pharmaceuticals and medical devices. Operating under the Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India, the CDSCO is responsible for approving new drugs, conducting clinical trials, setting standards for drugs, controlling the quality of imported drugs, and coordinating the activities of State Drug Control Organizations by providing expert advice.
Pharmacovigilance, on the other hand, is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The primary aim of pharmacovigilance is to ensure the safety and efficacy of medicines, thereby protecting public health.
In India, pharmacovigilance activities are monitored by the Pharmacovigilance Programme of India (PvPI), which works closely with CDSCO to collect, analyze, and act upon data regarding adverse drug reactions (ADRs). Together, they play a critical role in ensuring that the benefits of drugs outweigh their risks, maintaining high standards of patient safety, and promoting the rational use of medicines.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
The Gram stain is a fundamental technique in microbiology used to classify bacteria based on their cell wall structure. It provides a quick and simple method to distinguish between Gram-positive and Gram-negative bacteria, which have different susceptibilities to antibiotics
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
2. COVID19: The Triage and Isolation Problem
• Only 41% had fever on presentation to hospital
• Symptoms may be very mild or asymptomatic (like a mild cold)
• Viral shedding (most contagious) during early, mild phase
• PCR lab testing is imperfect, 71% sensitive
• Critical illness begins in second week of infection
Triage screening needs to be sensitive but will not be specific →
Many must be isolated upon entry to healthcare setting to prevent
inadvertent healthcare worker infection and nosocomial spread
3. Window for Action in the ED is NOW
• Screen with a broad net to identify patients that require isolation
• Healthcare workers use PPE & sanitation measures to prevent personal infection
• Isolate potential COVID-19 patients from others to prevent nosocomial spread
• Critical illness develops in 2nd week = 7 days of community COVID-19 spread
• Imperfect lab test: infections will be missed when the local infection rate is high
NOW this is a public health emergency
NOW is the time to prevent spread to frontline healthcare workers
This CANNOT business as usual in the ED
4. COVID19: Triage and Isolation Problem
How can we tell who is infected with SARS-CoV-19?
Fever
Shortness of Breath
Cough
Fatigue
Asymptomatic
Source: https://www.nejm.org/doi/full/10.1056/NEJMoa2002032
3/12/2020
5. COVID19: Resource Constraints
• High need for PPE and anticipated shortages as supply is ramped up
• Community centers with capacity are unable to screen patients due to lack of
N95 masks protection (required for testing)
• Patients must be isolated upon entering a building to prevent potential spread.
Construction of isolation rooms is very costly and does not take place overnight
• If healthcare providers become ill, they will need to isolate themselves for at least
14 days to prevent spread—our workforce is already understaffed, this will
devastate it
Our ability to address COVID-19 spread is limited by: physical plant
constraints, PPE shortages, and our ability to keep healthcare
providers well and safe.
6. COVID19: Risks
Decreasing the number of times a health care worker changes in and
out of PPE will decrease risk of self-contamination and spread
• Using tracers, healthcare workers were found to self-
contaminate 46% of the time when they removed gloves
• Doffing (taking off) PPE is the most likely time to be
contaminated
• Decreasing the number of times PPE is doffed decreases
risk (e.g. dedicated containment unit, wear suit all day)
Source: https://www.ncbi.nlm.nih.gov/pubmed/26457544?dopt=Abstract
3/12/2020
46% Chance of Self-Contamination
Every Time Gloves Removed
7. Operational Changes to Address Constraints/Risk
We should address these constraints by both:
1. Increasing supply and treatments and
2. Decreasing demand and risk
• More staff to screen,
care and clean
• More PPE/safe reuse
• More equipment such
as ventilators
• More equipment
• Treatments
Increase Supply/Treatment
• Reorganize to decrease
exposure
• Change operational practices
to concentrate/decrease
exposure
• Utilize video intercom to
decrease touches →
decreased risk and conserve
PPE
• Public health to “flatten the
curve”
Decrease Demand/Risk
3/12/2020
8. COVID19: Minimizing Risks by Minimizing
Touches
Opportunity to decrease health care worker infection and PPE usage
by an order of magnitude by minimizing unnecessary exposures
Source: https://www.ncbi.nlm.nih.gov/pubmed/26457544?dopt=Abstract
Business As Usual Decreased Physical Encounters
# of Episodes of Donning and
Doffing/Patient Encounter
5
# of Patients 100
Risk of Contamination/Episode 46%
Possible Contaminations 230
# of Episodes of Donning and
Doffing/Patient Encounter
0.5
# of Patients 100
Risk of Contamination/Episode 46%
Possible Contaminations 23
3/12/2020
9. Video Intercom in Hospital: Decrease risk and
conserve PPE
Changing our practice to incorporate use of video intercom and
limited physical exam could decrease healthcare worker infections
and greatly decrease our use of PPE
Business As Usual
• Multiple entries by team
• History taken in room
• Many opportunities for
self-contamination
• Room requires 2+ hour
turnaround after
discharge
• Full exam required for
high acuity patients only
Video Intercom in Room
• History taken via room
video intercom
• “Doorway” exam may be
sufficient to establish
acuity, stability (no entry)
• Coordination with staff to
minimize exposures,
• Fewer healthcare worker
infections, decreased
nosocomial spread
• Greatly decreased PPE use
Changing our practice to incorporate use of video intercom and
limited physical exam could decrease healthcare worker infections
and greatly decrease our use of PPE
10. Checkpoint Triage and Disposition
Business As Usual Checkpoint Triage
Triage Screening
Neg Screen PathwayPositive Screen Pathway
• Physical isolation/space
• Masking
• PPE use with every
physical visit
• 2+ hour room clean
• Normal operations
• Dependent on screening
to protect against
exposure
• Long TAT from positive
screen pathway rooms
leads to long waits
Triage Screening, Testing &
Discharge
Positive
Screen
AND Sick
• Isolation
pathway
Positive Screen
& NOT Sick
• Discharge from
checkpoint
• Minimal staff &
patient exposure
• No use of PPE and
room resources
Neg Screen
• Normal
operations
• In situations of
very high demand
or risk e.g.
asymptomatic
infection, patients
who do not need
stabilizing care
discharged from
checkpoint
A triage checkpoint outside of the building and
flexibility to operate under “crisis standard of
care” can limit exposure and decrease demands
on limited resources (PPE, rooms, staff)
Could be a
tent, video
kiosk, drive
through, etc.
3/12/2020
11. Reorganizing Work + Video Telemedicine to Decrease Risk
and Enable Physicians on Isolation to Work Remotely
Possible COVID Pathway/Unit Negative Screen Pathway/Unit
Procedure &
Exam Doctor
Nurses
Procedure &
Exam Doctor
Nurses
PPENeeds
Physicians In
Performing
Work Remotely
Changing organizational practices could
limit the risk to a smaller subset of the
healthcare workforce, conserve PPE and
extend physician workforce
12. What we need to do NOW:
Checkpoint triage, screening and disposition to minimize exposure and
to discharge potentially infected but well directly from tent/car
OUTSIDE of building
Video intercom to eliminate risk of unnecessary exposure, conserve
PPE and allow isolated or infected physicians to work from home
Changes to organization of work to concentrate risk
Implementation of “Crisis Standards of Care” to allow us to discharge
patients from triage if they do not need stabilization and we do not
have necessary resources to care for higher acuity patients
13. Significant Barriers to Quickly Implementing Practices
We Know Can Mitigate Disaster and Need to Be
Implemented NOW:
• Concerns about EMTALA compliance ($104K personal fine to physician per violation):
Reinforces “business as usual,” which places HCW at risk• f
• Concerns about crisis standards of care and subsequent malpractice liability: Prevents
development of innovative, safer approaches to care
• HIPAA and security regulatory compliance concerns on the part of hospitals prevent
speedy implementation of technology: Reinforces “business as usual” and prevents IT
departments from quickly implementing solution that isn’t fully “vetted”
14. Resources to Leverage
• Enlist our leading tech companies with expertise to quickly deliver needed solutions
and develop novel solutions
• “Borrow” personnel from companies for key areas of assistance e.g. strategy, project
management, IT, construction
• Coordinators who can help direct and prioritize needs for financial assistance as well as
informational needs
• Volunteers who can work from home e.g. case tracking or provide services such as
childcare to front line health care workers• Stra
• strategy and